Koshkin, Vadim S.
Patel, Vaibhav G.
Ali, Alicia
Bilen, Mehmet A.
Ravindranathan, Deepak
Park, Joseph J.
Kellezi, Olesia
Cieslik, Marcin
Shaya, Justin
Cabal, Angelo
Brown, Landon http://orcid.org/0000-0002-5231-4859
Labriola, Matthew
Graham, Laura S.
Pritchard, Colin
Tripathi, Abhishek
Nusrat, Sanober
Barata, Pedro
Jang, Albert http://orcid.org/0000-0002-0461-6174
Chen, Shuang R.
Garje, Rohan http://orcid.org/0000-0002-7244-5602
Acharya, Luna
Hwang, Clara http://orcid.org/0000-0002-0998-323X
Pilling, Amanda
Oh, William http://orcid.org/0000-0001-5113-8147
Jun, Tomi
Natesan, Divya
Nguyen, Chris
Kilari, Deepak
Pierro, Michael
Thapa, Bicky
Cackowski, Frank
Mack, Alleda
Heath, Elisabeth http://orcid.org/0000-0003-1381-2713
Marshall, Catherine H.
Tagawa, Scott T. http://orcid.org/0000-0003-2777-8587
Halabi, Susan
Schweizer, Michael T.
Armstrong, Andrew http://orcid.org/0000-0001-7012-1754
Dorff, Tanya http://orcid.org/0000-0001-5990-298X
Alva, Ajjai
McKay, Rana http://orcid.org/0000-0002-0581-7963
Article History
Received: 15 February 2021
Revised: 24 May 2021
Accepted: 21 July 2021
First Online: 6 August 2021
Competing interests
: VSK received research funding to his institution from Janssen, Nektar, Endocyte, Clovis. He has received compensation as a member of the scientific advisory board of Janssen, Clovis, Pfizer, Seattle Genetics/Astellas, Dendreon, AstraZeneca, EMD Serono. All funding received is for work performed outside the scope of this study. MAB received research funding to his institution from Xencor, Bayer, Bristol-Myers Squibb, Genentech/Roche, Seattle Genetics, Incyte, Nektar, AstraZeneca, Tricon Pharmaceuticals, Genome & Company, AAA, Peloton Therapeutics, and Pfizer. He has received compensation as a member of the scientific advisory board or as paid consultant of Exelixis, Bayer, BMS, Eisai, Pfizer, AstraZeneca, Janssen, Calithera Biosciences, Genomic Health, Nektar, and Sanofi. All funding received is for work performed outside the scope of this study. CP has consulted for AstraZaneca and received compensation for work performed outside the scope of this study. AT received research funding to his institution from EMD Serono, Aravive Inc, and Wndmil therapeutics. He has received compensation as a member of the scientific advisory board of Exilixis, EMD Serono, Genzyme, Foundation, and Pfizer. All funding received is for work performed outside the scope of this study. PB received research funding to his institution from AstraZeneca, Merck, Blue Earth Diagnostics. He has received compensation as a member of the scientific advisory board of Bristol Myers Squibb, Exelexis, Janseen, Pfizer, Sanofi, Dendreon, Caris, Bayer, EMD Serono. All funding received is for work performed outside the scope of this study. CH received research funding to his institution from AstraZeneca, Bayer, Dendreon, Merck. She has stock ownership in Johnson & Johnson. All funding received is for work performed outside the scope of this study. WO is an employee of Sema4 as Chief Medical Science Officer. He has consulted for and received funding from Amgen, Astellas, Bayer, AstraZeneca, Genzyme, Janssen, and Pfizer. All funding received is for work performed outside the scope of this study. EH received research funding to her institution from Caris. She has consulted for and received compensation from Caris. All funding received is for work performed outside the scope of this study. CHM is an employee of McGraw Hill. She has consulted for and received compensation from Dendreon and Bayer. All funding received is for work performed outside the scope of this study. STT received research funding to his institution from Sanofi, Medivation, Astellas, Janssen, rogenics, Dendreon, Newlink, Inovio, Immunomedics, Atlab, Boehringer Ingelheim, Millennium, Bayer, Merck, Abbvie, Karyopharm, Endocyte, Clovis, and Novartis. He has received personal honoraria from Sanofi, Medivation/Astellas, Dendreon, Janssen, Genentech, Bayer, Endocyte, Eisai, Immunomedics, Karyopharm, Abbvie, Tolmar, Seattle Genetics, Amgen, Clovis, QED, Pfizer, AAA/Novartis, Genomic Health, POINT Biopharma, Blue Earth Diagnostics. All funding received is for work performed outside the scope of this study. MTS received research funding to his institution from Zenith Epigenetics, Bristol Myers Squibb, Merck, Immunomedics, Janssen, AstraZeneca, Pfizer, Madison Vaccines, Tmunity and Hoffman-La Roche. He has consulted for and received compensation from Janssen and Resverlogix. All funding received is for work performed outside the scope of this study. A Armstrong received research funding to his institution from Merck, Bayer, Pfizer, Astellas, Janssen, Genentech/Roche, Constellation, Beigene, BMS, AstraZeneca. He consulted for and received compensation from Merck, Bayer, Pfizer, Astellas, Janssen, AstraZeneca, and Clovis. All funding received is for work performed outside the scope of this study. A Alva received research funding to his institution from MSD, AstraZeneca, Bristol-Myers Squibb, Astellas, Seattle Genetics, Genentech, Pfizer, Progenics, Prometheus, Eli Lilly, ASCO, Celgene, and Harpoon Therapeutics. He has received compensation as a member of the advisory board and as paid consultant for MSD, Bristol-Myers Squibb, AstraZeneca, Genentech, Roche, Pfizer, Progenics, and Prometheus. All funding received is for work performed outside the scope of this study. RM received research funding to her institution from Bayer, Pfizer, and Tempus. She has received compensation as a member of the advisory board for AstraZeneca, Bayer, Bristol Myers Squibb, Calithera, Exelixis, Janssen, Merck, Novartis, Pfizer, Sanofi, and Tempus. She consulted for and received compensation for Dendreon and Vividion. She serves on the molecular tumor board at Caris. All funding received is for work performed outside the scope of this study. VGP, A Ali, DR, JJP, OK, MC, JS, AC, LB, ML, LSG, SN, AJ, SRC, RG, LA, AP, TJ, DN, CN, DK, MP, BT, FC, AM, SH, and TD have no competing interests to disclose.